Literature DB >> 11668437

An animal model for delayed hemolytic transfusion reactions.

P M Ness1, R S Shirey, M H Weinstein, K E King.   

Abstract

Delayed hemolytic transfusion reactions (DHTRs) are a well-known complication of transfusion that may be defined as immune-mediated hemolysis of allogeneic donor red cells that occurs approximately 3 to 5 days after transfusion. In general, DHTRs occur in patients who have been alloimmunized previously, but the antibody titers have fallen below serologically detectable levels. Transfusion of seemingly compatible blood and exposure to the putative alloantigen results in an anamnestic immune response that may lead to in vivo accelerated destruction of donor red cells. Symptoms may include a drop in hemoglobin and hematocrit, fever, jaundice, and renal insufficiency. More recent studies have shown that there is a subset of cases called delayed serologic transfusion reactions (DSTRs) when there are serologic findings consistent with DHTRs but no clinical evidence of hemolysis. In both DHTRs and DSTRs, direct antiglobulin tests are often persistently positive long after the transfused donor red cells should have been removed from the circulation. Because the studies required to investigate the immunologic and clinical aspects of these reactions are precluded in humans, we developed an animal model for the study of DHTRs and DSTRs. Our article provides a comprehensive review of DHTRs and DSTRs, the role of complement and cytokines in these reactions, and the phenomenon of bystander hemolysis. We describe our studies using the rabbit as a model for the study of DHTRs and bystander hemolysis. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668437     DOI: 10.1053/tmrv.2001.26959

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  4 in total

1.  Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis.

Authors:  Eldad A Hod; Set A Sokol; James C Zimring; Steven L Spitalnik
Journal:  Int J Clin Exp Pathol       Date:  2008-05-30

Review 2.  Lessons learned from mouse models of hemolytic transfusion reactions.

Authors:  Eldad A Hod; James C Zimring; Steven L Spitalnik
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

3.  Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions.

Authors:  Eldad A Hod; Chantel M Cadwell; Justine S Liepkalns; James C Zimring; Set A Sokol; David A Schirmer; Jeffrey Jhang; Steven L Spitalnik
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

4.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.